Cargando…

Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model

The recent emergence of the SARS-CoV-2 Omicron variant of concern (VOC), which contains a heavily mutated spike protein capable of escaping preexisting immunity, identifies a continued need for interventional measures. Molnupiravir (MK-4482), an orally administered nucleoside analog, has demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenke, Kyle, Okumura, Atsushi, Lewis, Matthew C., Feldmann, Friederike, Meade-White, Kimberly, Bohler, W. Forrest, Griffin, Amanda, Rosenke, Rebecca, Shaia, Carl, Jarvis, Michael A., Feldmann, Heinz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310535/ https://www.ncbi.nlm.nih.gov/pubmed/35579953 http://dx.doi.org/10.1172/jci.insight.160108

Ejemplares similares

Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model
por: Rosenke, Kyle, et al.
Publicado: (2022)

Combined molnupiravir-nirmatrelvir treatment improves the inhibitory effect on SARS-CoV-2 in macaques
por: Rosenke, Kyle, et al.
Publicado: (2023)

Combined Molnupiravir and Nirmatrelvir Treatment Improves the Inhibitory Effect on SARS-CoV-2 in Rhesus Macaques
por: Rosenke, Kyle, et al.
Publicado: (2022)

Histopathologic Characterization of Experimental Peracute SARS-CoV-2 Infection in the Syrian Hamster
por: Clancy, Chad S., et al.
Publicado: (2023)

SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract
por: Hansen, Frederick, et al.
Publicado: (2022)

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Rosenke, Kyle, et al.
Publicado: (2020)

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Rosenke, Kyle, et al.
Publicado: (2021)

Alkhurma haemorrhagic fever virus causes lethal disease in IFNAR(-/-) mice
por: Bhatia, Bharti, et al.
Publicado: (2021)

SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta
por: van Doremalen, Neeltje, et al.
Publicado: (2022)

SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta
por: van Doremalen, Neeltje, et al.
Publicado: (2022)

Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
por: Rosenke, Kyle, et al.
Publicado: (2020)

Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
por: Rosenke, Kyle, et al.
Publicado: (2020)

UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates
por: Rosenke, Kyle, et al.
Publicado: (2021)

Ebola Virus IgG Seroprevalence in Southern Mali
por: Bane, Sidy, et al.
Publicado: (2021)

Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates
por: Bhatia, Bharti, et al.
Publicado: (2023)

Identifying Early Target Cells of Nipah Virus Infection in Syrian Hamsters
por: Baseler, Laura, et al.
Publicado: (2016)

Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine
por: Hawman, David W., et al.
Publicado: (2022)

Domestic Pig Unlikely Reservoir for MERS-CoV
por: de Wit, Emmie, et al.
Publicado: (2017)

Lassa Virus Treatment Options
por: Hansen, Frederick, et al.
Publicado: (2021)

Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2
por: Rosenke, Kyle, et al.
Publicado: (2020)

Pathogenesis and Host Response in Syrian Hamsters following Intranasal Infection with Andes Virus
por: Safronetz, David, et al.
Publicado: (2011)

Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models
por: Rosenke, Kyle, et al.
Publicado: (2020)

A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
por: Safronetz, David, et al.
Publicado: (2015)

UK B.1.1.7 variant exhibits increased respiratory replication and shedding in nonhuman primates
por: Rosenke, K., et al.
Publicado: (2021)

Mastomys natalensis Has a Cellular Immune Response Profile Distinct from Laboratory Mice
por: Tang-Huau, Tsing-Lee, et al.
Publicado: (2021)

Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model
por: de Wit, Emmie, et al.
Publicado: (2022)

Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus
por: Hawman, David W, et al.
Publicado: (2021)

Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route
por: Munster, Vincent J., et al.
Publicado: (2012)

Recovery from acute SARS-CoV-2 infection and development of anamnestic immune responses in T cell-depleted rhesus macaques
por: Hasenkrug, Kim J., et al.
Publicado: (2021)

Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques
por: Hasenkrug, Kim J., et al.
Publicado: (2021)

Continuing Orthohantavirus Circulation in Deer Mice in Western Montana
por: Williamson, Brandi N., et al.
Publicado: (2021)

Lack of Protection Against Ebola Virus from Chloroquine in Mice and Hamsters
por: Falzarano, Darryl, et al.
Publicado: (2015)

A live-attenuated viral vector vaccine protects mice against lethal challenge with Kyasanur Forest disease virus
por: Bhatia, Bharti, et al.
Publicado: (2021)

Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease
por: Monath, Thomas P., et al.
Publicado: (2023)

Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys
por: Speranza, Emily, et al.
Publicado: (2021)

Evaluation of viral load in patients with Ebola virus disease in Liberia: a retrospective observational study
por: Matson, M Jeremiah, et al.
Publicado: (2022)

Characterization of a novel STAT 2 knock-out hamster model of Crimean-Congo hemorrhagic fever virus pathogenesis
por: Ranadheera, Charlene, et al.
Publicado: (2020)

Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge
por: Marzi, Andrea, et al.
Publicado: (2019)

Development of a nonhuman primate model for mammalian bornavirus infection
por: Schlottau, Kore, et al.
Publicado: (2022)

Use of Favipiravir to Treat Lassa Virus Infection in Macaques
por: Rosenke, Kyle, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_faph7bnrl1ouve9jupf8t7hq53